Behcet's syndrome pathophysiology and potential therapeutic targets

被引:51
|
作者
Emmi, Giacomo [1 ]
Silvestri, Elena [1 ,2 ,3 ]
Squatrito, Danilo [2 ,3 ]
D'Elios, Mario Milco [1 ,2 ,3 ]
Ciucciarelli, Lucia [1 ]
Prisco, Domenico [1 ,2 ,3 ]
Emmi, Lorenzo [2 ,3 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy
[2] AOU Careggi, SOD Patol Med, Ctr Autoimmune Syst Dis, Behcet Ctr, Florence, Italy
[3] AOU Careggi, Lupus Clin, Florence, Italy
关键词
Behcet syndrome pathophysiology; Behcet treatment; Biologic therapy; Anti-TNF-alpha; IL-1 blocking agents; GENOME-WIDE ASSOCIATION; TUMOR-NECROSIS-FACTOR; V-GAMMA-9/V-DELTA-2; T-LYMPHOCYTES; FAMILIAL MEDITERRANEAN FEVER; INTERFERON ALPHA-2A; STREPTOCOCCUS-SANGUIS; DOUBLE-BLIND; TNF FAMILY; DISEASE; UVEITIS;
D O I
10.1007/s11739-013-1036-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet syndrome is a systemic inflammatory disorder characterized by multiorgan involvement such as oral and genital ulcers, uveitis, skin lesions as well as by less frequent, but often more severe, central nervous system and vascular manifestations. The pathogenetic mechanisms are still incompletely known; however the interaction between a specific genetic background and environmental or infectious factors certainly contributes to the immune dysregulation that characterizes this disease. The discovery of new immunological pathways in Behcet syndrome pathogenesis may help us to set up new treatments. In this review, we will focus our attention on the possible mechanisms underlying Behcet syndrome pathogenesis and their potential role as novel therapeutic targets.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 50 条
  • [41] Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
    Toth-Manikowski, Stephanie
    Atta, Mohamed G.
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [42] Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets
    Zakynthinos, E.
    Daniil, Z.
    Papanikolaou, J.
    Makris, D.
    CURRENT DRUG TARGETS, 2011, 12 (04) : 501 - 513
  • [43] SLEEP AND NIGHTLY ORAL DRYNESS AS POTENTIAL THERAPEUTIC TARGETS TO REDUCE FATIGUE IN SJOGREN'S SYNDROME
    Van Leeuwen, Ninke
    Bossema, Ercolie R.
    Kruize, Aike A.
    Bootsma, Hendrika
    Bijlsma, Johannes W.
    Geenen, Rinie
    PSYCHOSOMATIC MEDICINE, 2013, 75 (03): : A156 - A157
  • [44] Pathophysiology of bronchial inflammation: Chemoreceptors as therapeutic targets
    Marshall, GD
    ALLERGY AND ASTHMA PROCEEDINGS, 2000, 21 (05) : 309 - 313
  • [45] Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy
    Alsahhar, Jamil S.
    Rahimi, Robert S.
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 145 - 154
  • [46] Cushing's syndrome:: drug targets and therapeutic options
    Páez-Pereda, M
    Arzt, E
    Stalla, GK
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (10) : 1537 - 1546
  • [47] Sjogren's syndrome: Old and new therapeutic targets
    Mavragani, Clio P.
    Moutsopoulos, Haralampos M.
    JOURNAL OF AUTOIMMUNITY, 2020, 110
  • [48] β-Arrestins as Potential Therapeutic Targets for Alzheimer's Disease
    Jiang, Teng
    Yu, Jin-Tai
    Tan, Meng-Shan
    Zhu, Xi-Chen
    Tan, Lan
    MOLECULAR NEUROBIOLOGY, 2013, 48 (03) : 812 - 818
  • [49] β-Arrestins as Potential Therapeutic Targets for Alzheimer’s Disease
    Teng Jiang
    Jin-Tai Yu
    Meng-Shan Tan
    Xi-Chen Zhu
    Lan Tan
    Molecular Neurobiology, 2013, 48 : 812 - 818
  • [50] Are Lysosomes Potential Therapeutic Targets for Parkinson's Disease?
    Petese, Alessandro
    Cesaroni, Valentina
    Cerri, Silvia
    Blandini, Fabio
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2022, 21 (08) : 642 - 655